Back to News
Market Impact: 0.25

Prediction: Intel Stock's Best Days Are Behind It -- and Here's the Chip Stock to Buy Instead

INTCAVGONFLXNVDANDAQ
Artificial IntelligenceCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsTechnology & InnovationMarket Technicals & FlowsAnalyst Insights
Prediction: Intel Stock's Best Days Are Behind It -- and Here's the Chip Stock to Buy Instead

Intel reported first-quarter 2026 revenue growth of 7% year over year and adjusted EPS of $0.29, more than double the prior year, with its data center and AI segment up 22% to $5.1 billion. However, the article argues the stock's 300%+ run and $427 billion market cap have outpaced fundamentals, with valuation now around 73x annualized quarterly adjusted EPS. Broadcom is highlighted as the preferred chip stock, supported by 29% revenue growth to $19.3 billion and AI semiconductor revenue surging 106% to $8.4 billion.

Analysis

The key market signal is not that Intel is “fixed,” but that investors have already started discounting a near-perfect execution path: sustained supply relief, faster margin expansion, and no stumble in the AI/server cycle. That creates a fragile setup because the next leg of upside now depends less on incremental operating improvement and more on multiple maintenance, which is much harder once the turnaround narrative is fully owned. In contrast, Broadcom’s demand is more contractually embedded and less hostage to a single-cycle re-rating, so its premium can persist longer if custom silicon order visibility remains intact. The second-order effect is competitive pressure inside the AI infrastructure stack. If Intel keeps regaining share in Xeon and adjacent datacenter sockets, the most immediate pressure is not on Nvidia’s GPU lead, but on the ecosystem around networking, chip packaging, and board-level suppliers that had priced in a one-way share grab by incumbents. However, the bigger risk to the long side in Intel is a pause in AI capex, because a stock that has already monetized a full turnaround can de-rate sharply if growth merely normalizes instead of accelerating. The contrarian read is that the market may be underestimating how cyclical the “AI beneficiary” label remains for Intel, while overestimating how smooth Broadcom’s customer concentration is. Broadcom’s revenue visibility is excellent until one or two hyperscalers rationalize custom silicon spending; then the stock behaves less like a compounder and more like a levered capex proxy. That makes the spread trade more attractive than either outright long: Intel has more valuation fragility, but Broadcom has more consensus complacency around customer durability. For timing, the next 1-2 quarters matter more than the next year: any earnings beat that comes from temporary supply constraints rather than true end-demand strength will be a fade signal for Intel. Broadcom’s setup is better as long as management keeps raising AI revenue guidance, but the asymmetry worsens if order commentary stops accelerating. In short, the market is rewarding “proof,” but the tradeable edge is in distinguishing proof from peak optimism.